When depression has not improved with standard antidepressants, the question is usually not just whether a new treatment might help. It is also what the actual experience will be like. For many patients, understanding how Spravato treatment sessions work makes the process feel less intimidating and more manageable.
Spravato is the brand name for esketamine, an FDA-approved treatment for adults with treatment-resistant depression and, in some cases, major depressive disorder with acute suicidal thoughts or behaviors. Unlike a traditional antidepressant that is taken at home, Spravato is administered in a certified medical office under supervision. That structure is a key part of the treatment, not an inconvenience. It is designed to support both safety and effectiveness.
Why Spravato sessions are different
Most depression medications are prescribed for home use, with follow-up visits spaced out over weeks or months. Spravato works differently. It is given as a nasal spray in a monitored clinical setting because it can cause temporary side effects such as dissociation, dizziness, sedation, or an increase in blood pressure.
That does not mean the treatment is unsafe. It means the treatment is carefully controlled. Patients are observed during and after each session so the care team can monitor how they are feeling, check vital signs, and make sure they are ready to leave safely.
For people who have spent a long time trying one medication after another, this can feel unfamiliar at first. It can also feel reassuring. You are not being sent home to figure it out on your own. You are being supported through each step.
How Spravato treatment sessions work from start to finish
The first step is not the treatment day itself. It is a psychiatric evaluation to determine whether Spravato is an appropriate option. Because this treatment is intended for specific clinical situations, a provider will review your diagnosis, treatment history, current medications, medical background, and overall goals of care.
If Spravato is recommended, your treatment plan will include a schedule, office-based monitoring, and guidance about how to prepare. Patients are usually told not to eat for at least two hours before treatment and not to drink liquids for at least 30 minutes beforehand. Your provider may also review which medications to take as usual and whether any adjustments are needed.
On the day of the session, you will arrive at the office and check in. Because you cannot drive yourself home after treatment, transportation needs to be arranged in advance. This part matters. Even if you end up feeling fairly normal afterward, the restriction is there for safety.
Before the medication is given, the clinical team checks in on how you are doing and measures your blood pressure. If there are concerns such as elevated blood pressure, illness, or another issue that changes the risk profile that day, the session may be delayed or adjusted. Good treatment is not rushed treatment.
Spravato is self-administered as a nasal spray under supervision. That means the patient uses the device, but only in the office and with clinical guidance. The number of devices used depends on the prescribed dose. There is usually a short pause between devices so the medication can be administered correctly.
Once the dose is complete, the monitoring period begins. Patients stay in the office for at least two hours after administration. During that time, they rest in a supervised setting while staff observe for side effects and check blood pressure at intervals.
What Spravato feels like during a session
One of the most common concerns patients have is whether they will “lose control” during treatment. Experiences vary, but most side effects are temporary and begin to wear off during the observation period.
Some patients describe feeling sleepy, lightheaded, or disconnected from their surroundings. Others notice a floating sensation, mild nausea, changes in perception, or difficulty concentrating for a short time. Not everyone has the same reaction, and not every session feels identical. The first few sessions can feel the most unfamiliar simply because the experience is new.
This is where the office setting helps. You are not expected to push through side effects alone. The treatment team is there to monitor you, answer questions, and help you stay comfortable while the medication wears off.
In many cases, patients spend the observation period quietly resting. Some prefer low stimulation and simply sit back with their eyes closed. Others may talk briefly with staff or a support person if the practice allows one to accompany them. The goal is not to perform or process anything on the spot. The goal is safe, calm medical observation.
The schedule: why treatment starts more frequently
Understanding how Spravato treatment sessions work also means understanding the timeline. Spravato is not typically given once and then continued casually as needed. It follows a structured treatment schedule.
During the induction phase, sessions are usually scheduled twice weekly for four weeks. After that, frequency often decreases to once weekly for a period of time, then possibly every other week depending on response and the provider’s clinical judgment. Some patients continue maintenance treatment longer term, while others may need a different plan.
This schedule exists for a reason. Early sessions are designed to build a therapeutic effect, and later sessions are adjusted based on how symptoms change over time. The right pace depends on the individual. Some people notice improvement relatively early. For others, progress is more gradual.
Spravato is also used together with an oral antidepressant for treatment-resistant depression. That combination is part of the FDA-approved approach. In practice, this means your psychiatrist is not just looking at the session itself but at your broader treatment plan, including medication management and ongoing symptom monitoring.
What happens after each appointment
After the observation period, the team confirms that you are stable for discharge. Even then, the day is not considered business as usual. Patients should not drive, operate machinery, return to work that requires full concentration, or make major decisions until the next day after a restful night’s sleep.
Most people go home and take it easy. Some feel tired for the remainder of the day. Others feel emotionally lighter but still somewhat foggy. A ride home is required because it can take time for alertness and coordination to fully return.
What matters over the longer term is not just how you feel in the hour after treatment, but how your depression symptoms change across days and weeks. Your provider will track this with follow-up conversations, symptom measures, and clinical review.
Who may be a good fit for Spravato
Spravato is often considered for adults with treatment-resistant depression, meaning depression that has not improved adequately after trying at least two antidepressants. It may also be considered in certain urgent depressive situations, depending on the diagnosis and clinical need.
Still, not every patient with difficult depression is automatically a candidate. Medical history matters. So do blood pressure concerns, substance use history, current medications, pregnancy status, and other psychiatric or neurological factors. That is why a careful evaluation comes first.
For some patients, another evidence-based option such as TMS may be a better fit. In other cases, Spravato may be part of a larger plan that includes medication management and psychotherapy. Effective psychiatric care is rarely one-size-fits-all.
Questions to ask before starting
If you are considering treatment, it helps to ask practical questions, not just clinical ones. How long will each visit take door to door? What side effects are most common in your case? How will progress be measured? What should you do if you feel anxious before a session? These questions are not minor. They help you prepare realistically.
It is also worth asking how the office supports patients through the process. A strong Spravato program should feel structured, medically sound, and easy to understand. At Brainiac Behavioral Health, Spravato treatment is offered in Orange and Anaheim Hills within a broader model of evidence-based psychiatric care, which can be especially helpful for patients who need more than a single treatment option.
If you have been living with persistent depression, needing a supervised in-office treatment does not mean your condition is beyond help. It means there are science-backed care options designed for situations where standard treatment has not been enough. Sometimes hope returns not all at once, but through a process that feels safe, steady, and possible.